191 related articles for article (PubMed ID: 2438053)
21. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
Halperin SA; King J; Law B; Mills E; Willems P
Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624
[TBL] [Abstract][Full Text] [Related]
22. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.
Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB
Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642
[TBL] [Abstract][Full Text] [Related]
23. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
24. Use of synthetic peptides to map antigenic sites of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Abens J; Undén A; Bartfai T
J Infect Dis; 1988 Apr; 157(4):738-42. PubMed ID: 2450153
[TBL] [Abstract][Full Text] [Related]
25. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
Ladhani SN; Andrews NJ; Southern J; Jones CE; Amirthalingam G; Waight PA; England A; Matheson M; Bai X; Findlow H; Burbidge P; Thalasselis V; Hallis B; Goldblatt D; Borrow R; Heath PT; Miller E
Clin Infect Dis; 2015 Dec; 61(11):1637-44. PubMed ID: 26374816
[TBL] [Abstract][Full Text] [Related]
26. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
[TBL] [Abstract][Full Text] [Related]
27. Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertussis toxin-tetanus toxin hybrid protein.
Abomoelak B; Huygen K; Kremer L; Turneer M; Locht C
Infect Immun; 1999 Oct; 67(10):5100-5. PubMed ID: 10496883
[TBL] [Abstract][Full Text] [Related]
28. Carrier-induced epitopic suppression, a major issue for future synthetic vaccines.
Schutze MP; Leclerc C; Jolivet M; Audibert F; Chedid L
J Immunol; 1985 Oct; 135(4):2319-22. PubMed ID: 2411793
[TBL] [Abstract][Full Text] [Related]
29. Identification of T- and B-cell epitopes of the S2 and S3 subunits of pertussis toxin by use of synthetic peptides.
Chong P; Zobrist G; Sia C; Loosmore S; Klein M
Infect Immun; 1992 Nov; 60(11):4640-7. PubMed ID: 1383153
[TBL] [Abstract][Full Text] [Related]
30. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine.
Clemens JD; Ferreccio C; Levine MM; Horwitz I; Rao MR; Edwards KM; Fritzell B
JAMA; 1992 Feb; 267(5):673-8. PubMed ID: 1731134
[TBL] [Abstract][Full Text] [Related]
31. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
[TBL] [Abstract][Full Text] [Related]
32. [An increase in the immunogenicity of bacterial antigens under the influence of one of the derivatives of muramyl dipeptide].
Britsina MV; Shepeleva IB; Baturo AP; Elkina SI; Kalina NG; Andronova TM; Ermolova EV; Zakharova NS; Ivanov VT; Sokolova TV
Zh Mikrobiol Epidemiol Immunobiol; 1992; (5-6):43-5. PubMed ID: 1455969
[TBL] [Abstract][Full Text] [Related]
33. Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines.
Baker JD; Halperin SA; Edwards K; Miller B; Decker M; Stephens D
J Pediatr; 1992 Oct; 121(4):523-7. PubMed ID: 1403383
[TBL] [Abstract][Full Text] [Related]
34. Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components.
Dagan R; Goldblatt D; Maleckar JR; Yaïch M; Eskola J
Infect Immun; 2004 Sep; 72(9):5383-91. PubMed ID: 15322036
[TBL] [Abstract][Full Text] [Related]
35. A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection.
Patel SS; Wagstaff AJ
Drugs; 1996 Aug; 52(2):254-75. PubMed ID: 8841742
[TBL] [Abstract][Full Text] [Related]
36. Carrier-induced epitope-specific regulation and its bypass in a protein-protein conjugate.
Kaliyaperumal A; Chauhan VS; Talwar GP; Raghupathy R
Eur J Immunol; 1995 Dec; 25(12):3375-80. PubMed ID: 8566026
[TBL] [Abstract][Full Text] [Related]
37. Engineering bacterial toxin for the development of new vaccine against pertussis.
Bartoloni A; Pizza M; Gross R; Perugini M; Arico B; Domenighini M; Rappuoli R
Tokai J Exp Clin Med; 1988; 13 Suppl():217-22. PubMed ID: 2483870
[TBL] [Abstract][Full Text] [Related]
38. Identification of linear B epitopes of pertactin of Bordetella pertussis induced by immunization with whole and acellular vaccine.
da Silva FR; Napoleão-Pego P; De-Simone SG
Vaccine; 2014 Oct; 32(47):6251-8. PubMed ID: 25252193
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity of specific Bordetella pertussis surface antigens in diphtheria-tetanus-pertussis (DTP) vaccines.
Blaskett AC; Cox JC
Epidemiol Infect; 1988 Jun; 100(3):335-44. PubMed ID: 2897927
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
